These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 8215567)

  • 1. Malformations, withdrawal manifestations, and hypoglycaemia after exposure to valproate in utero.
    Thisted E; Ebbesen F
    Arch Dis Child; 1993 Sep; 69(3 Spec No):288-91. PubMed ID: 8215567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal hypoglycaemia and withdrawal symptoms after exposure in utero to valproate.
    Ebbesen F; Joergensen A; Hoseth E; Kaad PH; Moeller M; Holsteen V; Rix M
    Arch Dis Child Fetal Neonatal Ed; 2000 Sep; 83(2):F124-9. PubMed ID: 10952707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproate and the risk for congenital malformations: Is formulation and dosage regime important?
    Mawhinney E; Campbell J; Craig J; Russell A; Smithson W; Parsons L; Robertson I; Irwin B; Morrison P; Liggan B; Delanty N; Hunt S; Morrow J
    Seizure; 2012 Apr; 21(3):215-8. PubMed ID: 22364656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal episodic hypoglycemia: a finding of valproic acid withdrawal.
    Çoban D; Kurtoğlu S; Akın MA; Akçakuş M; Güneş T
    J Clin Res Pediatr Endocrinol; 2010; 2(2):92-4. PubMed ID: 21274347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acid.
    Jäger-Roman E; Deichl A; Jakob S; Hartmann AM; Koch S; Rating D; Steldinger R; Nau H; Helge H
    J Pediatr; 1986 Jun; 108(6):997-1004. PubMed ID: 3086531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatal cardiac malformation in fetal valproate syndrome.
    Sodhi P; Poddar B; Parmar V
    Indian J Pediatr; 2001 Oct; 68(10):989-90. PubMed ID: 11758141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproic acid monotherapy in pregnancy and major congenital malformations.
    Jentink J; Loane MA; Dolk H; Barisic I; Garne E; Morris JK; de Jong-van den Berg LT;
    N Engl J Med; 2010 Jun; 362(23):2185-93. PubMed ID: 20558369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The fetal valproate syndrome.
    DiLiberti JH; Farndon PA; Dennis NR; Curry CJ
    Am J Med Genet; 1984 Nov; 19(3):473-81. PubMed ID: 6439041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose dependence of fetal malformations associated with valproate.
    Vajda FJ; O'Brien TJ; Graham JE; Lander CM; Eadie MJ
    Neurology; 2013 Sep; 81(11):999-1003. PubMed ID: 23911758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry.
    Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Sabers A; Perucca E; Vajda F;
    Lancet Neurol; 2011 Jul; 10(7):609-17. PubMed ID: 21652013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The frequency of neonatal morbidity after exposure to antiepileptic drugs in utero: a retrospective population-based study.
    Burja S; Rakovec-Felser Z; Treiber M; Hajdinjak D; Gajsek-Marchetti M
    Wien Klin Wochenschr; 2006; 118 Suppl 2():12-6. PubMed ID: 16817037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple congenital malformations including generalized hypertrichosis with gum hypertrophy in a child exposed to valproic acid in utero.
    Stoll C; Audeoud F; Gaugler C; Bernardin A; Messer J
    Genet Couns; 2003; 14(3):289-98. PubMed ID: 14577673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Is valproic acid teratogenic?].
    Robert E; Robert JM; Lapras C
    Rev Neurol (Paris); 1983; 139(6-7):445-7. PubMed ID: 6412342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased rate of major malformations in offspring exposed to valproate during pregnancy.
    Wyszynski DF; Nambisan M; Surve T; Alsdorf RM; Smith CR; Holmes LB;
    Neurology; 2005 Mar; 64(6):961-5. PubMed ID: 15781808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The risk of spina bifida aperta after first-trimester exposure to valproate in a prenatal cohort.
    Omtzigt JG; Los FJ; Grobbee DE; Pijpers L; Jahoda MG; Brandenburg H; Stewart PA; Gaillard HL; Sachs ES; Wladimiroff JW
    Neurology; 1992 Apr; 42(4 Suppl 5):119-25. PubMed ID: 1574165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproate-associated foetal malformations-Rates of occurrence, risks in attempted avoidance.
    Vajda FJE; O'Brien TJ; Graham JE; Hitchcock AA; Lander CM; Eadie MJ
    Acta Neurol Scand; 2019 Jan; 139(1):42-48. PubMed ID: 30109700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy after valproate withdrawal-Fetal malformations and seizure control.
    Vajda FJE; O'Brien TJ; Graham JE; Hitchcock AA; Lander CM; Eadie MJ
    Epilepsia; 2020 May; 61(5):944-950. PubMed ID: 32314363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal Valproate Syndrome.
    Mutlu-Albayrak H; Bulut C; Çaksen H
    Pediatr Neonatol; 2017 Apr; 58(2):158-164. PubMed ID: 27422007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysmorphic features: an important clue to the diagnosis and severity of fetal anticonvulsant syndromes.
    Kini U; Adab N; Vinten J; Fryer A; Clayton-Smith J;
    Arch Dis Child Fetal Neonatal Ed; 2006 Mar; 91(2):F90-5. PubMed ID: 16239295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The longer term outcome of children born to mothers with epilepsy.
    Adab N; Kini U; Vinten J; Ayres J; Baker G; Clayton-Smith J; Coyle H; Fryer A; Gorry J; Gregg J; Mawer G; Nicolaides P; Pickering L; Tunnicliffe L; Chadwick DW
    J Neurol Neurosurg Psychiatry; 2004 Nov; 75(11):1575-83. PubMed ID: 15491979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.